4//SEC Filing
Timol Bashir 4
Accession 0001140361-18-027711
CIK 0001602078other
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 5:01 PM ET
Size
7.8 KB
Accession
0001140361-18-027711
Insider Transaction Report
Form 4
Timol Bashir
Director10% Owner
Transactions
- Other
Common Stock
2018-06-05+27,082,000→ 27,082,100 total - Conversion
Series A Convertible Preferred Stock
2018-06-05−27,082→ 0 totalExercise: $0.00→ Common Stock, par value $0.01 (27,082,000 underlying)
Footnotes (3)
- [F1]The Reporting Person converted all of his shares of Series A Convertible Preferred Stock into Common Stock, whereby each share of Series A Convertible Preferred was converted into 1,000 shares of Common Stock.
- [F2]The Reporting Person can automatically convert after all of the following events occur:(a) the sugarBEAT(R) device to be commercialized has CE regulatory approval; (b) retail sales have commenced; and (c) retail sales exceed USD$5 million, which includes any advanced sales (the "Triggering Events"); the disinterested members of the Board shall confirm the satisfaction of all Triggering Events by written notice to the Corporation's transfer agent. The Reporting Person can voluntarily convert any shares of Series A Preferred then outstanding into fully paid and nonassessable shares of Common Stock.
- [F3]The conversion rights do not expire.
Documents
Issuer
Nemaura Medical Inc.
CIK 0001602078
Entity typeother
Related Parties
1- filerCIK 0001628660
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 5:01 PM ET
- Size
- 7.8 KB